1.3.3 EMC Statement
Guidance and manufacture's declaration –
electromagnetic emissions
The Continuous Glucose Monitoring Systems is suitable
for use in the specified electromagnetic environment (s) and
it has met the following standard’s emission requirements.
Guidance and manufacture's declaration –
electromagnetic immunity
The Continuous Glucose Monitoring Systems is suitable
for use in the specified electromagnetic environment (s) and
it has met the following immunity test levels. Higher immunity
levels may cause the Continuous Glucose Monitoring Systems’s
essential performance lost or degraded.
See the RF wireless
communication equipment
table in "Recommended
minimum separation
distances".
4
Recommended minimum separation distances
Nowadays, many RF wireless equipments have being
used in various healthcare locations where medical equipment
and/or systems are used. When they are used in close proximity
to medical equipment and/or systems, the medical equipment
and/or systems’ basic safety and essential performance may be
affected. Continuous Glucose Monitoring Systems has been
tested with the immunity test level in the below table and meet
the related requirements of IEC 60601-1-2:2014. The customer
and/or user should help keep a minimum distance between RF
wireless communications equipment and Continuous Glucose
Monitoring Systems as recommended below.
Содержание i3
Страница 1: ......
Страница 3: ...32 33 33 33 34 34 34 34 34 34 35 35 35 35 36 36 36 36 36 37 38 38 ...
Страница 4: ......
Страница 5: ......
Страница 42: ...17 Label symbol and graphic description 37 ...
Страница 44: ...I3 WJ XT SMS 01 version no A 0 effective date 2019 5 20 ...